NEWS01/11/2008: Robotic Pharmacist Mixing Chemo Drugs at U.S. Hospital Robot to Mix Chemotherapy Drugs at U.S. Hospital 12/20/2007: Robotic Workbench to Prepare Hazardous Drugs 12/17/2007: CytoCare showcased on CBS News 07/19/2007: University of Colorado Health System acquires CytoCare for advanced chemotherapy compounding. Surface Contamination of Chemotherapy Preparation Areas, Society of Hospital Pharmacist of Australia 08/07/2006: Deaths Spur Debate About Drugs Made in Pharmacies Summer, 2006: Getting Full Value from our Health Care System, Rand Corporations May, 2006: Chemotherapy: the Protocol Revolution, IMS, Pharmaceutiques Cancer: the Challenge Goes Commercial, IMS
|
|
 |
Using a robotic devise to automate the production of IV syringes and bags, your facility is able to produce syringes and bags in a sterile environment, reduce the possibility of human errors in compounding and labeling, ensure that labels and bar codes are affixed to each of the robot-prepared syringes or bags, improve the efficiency of your of your facility's IV syringe and bag production, and, ultimately, decrease the costs associated with IV products. |
 |
Substantial levels of cytotoxic drug contamination in drug preparation aras that utilise a CDSC [Cytotoxic Drug Safety Cabinet] were detected on a variety of surfaces. Reliance on CDSC to provide total protection from exposure to hazardous drugs is insufficient. Surface Contamination of Chemotherapy Preparation Areas with Antineoplastic Agents in Australian Hospital Pharmacy Departments |
 |
After three decades of research and development, advances in cancer therapy are
finally bearing fruit and fulfilling the promise of improved outcomes for million of
patients. There are more anti-cancer products in late-stage development than in any
other medical sector. The size of the market has doubled in the last five years. The
outlook for further growth has never been better. Cancer Goes Commercial, IMS. |
 |
Americans spend nearly $2 trillion a year on health care, but that’s about $1 trillion
more than what Americans should be spending for what they’re getting in return.
That’s the bold assertion of Paul O’Neill, former U.S. Secretary of the Treasury under
President George W. Bush. Read about IV waste at USA hospitals. Rand Corporation, Paul O'Neill's Getting Full Value from Our Health System |
|
It is anticipated that new molecules that target a mechanism, rather than a
particular cancer, will be widely utilized through new combinations with existing
chemotherapy treatments. Currently applied protocols will thus undergo thorough
rewriting. There will be new associations (surgery, chemotherapy, radiotherapy) with
variable sequences. The Protocol Revolution: By 2009, Most Chemotherapy Protocols Will be Re-written |
 |
In 8 days last summer, the same dangerous inflammation struck 3 cardiac surgery
patients at Mary Washington Hospital within hours of their operations. On
Sept. 2, one man died. The hospital later determined that at least 11 cardiac
surgery patients were stricken during a 10-month period from the end of December
2004 to September 2005, and three died. The illnesses and deaths drew attention to
a practice few patients know about: Some drugs, including high-risk sterile
preparations, are made in pharmacies under less-restrictive rules than those that drug companies follow. Death Spur Debate about drugs made in Pharmacies |
© 2007 PRIMUS INNOVATIONS, INC. All rights reserved |
|